BioTuesdays

Category - Developments

RPS Diagnostics, Atomo in FebriDx pact

Closely-held RPS Diagnostics and Atomo Diagnostics of Australia have entered into a commercial and development partnership to create next generation FebriDx tests that are anticipated to transform the diagnosis of...

Evotec

Evotec, MaRS announce first LAB 150 project

Evotec AG (Frankfurt Stock Exchange:EVT) and MaRS Innovation announced the first project to be developed under their LAB150 partnership would target an unmet medical need in skin inflammatory conditions. The project...